GlassScriptPhysician profile
Joshua E Mcadams
NPI 1326302548
$3,375.88
in general payments reported to CMS, 2019-2025
17 companies · $672 in 2025
The $672 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $267 · 2021: $278 · 2022: $515 · 2023: $484 · 2024: $602 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $847.17 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $678.80 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Sun Pharmaceutical Industries INC. | $420.78 | 2019-2025 | Cequa |
| Abbvie INC. | $321.51 | 2022-2025 | |
| Biotissue Holdings INC. | $227.56 | 2019-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $180.00 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $134.68 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $133.58 | 2021-2022 | |
| Alcon Vision LLC | $114.21 | 2023-2025 | Precision 1, Rocklatan, Dailies |
| Allergan, INC. | $106.96 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $62.56 | 2020 | |
| Sight Sciences, INC. | $43.01 | 2022 | |
| Oyster Point Pharma, INC. | $33.88 | 2022 | |
| Optos, INC. | $23.67 | 2021 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $16.04 | 2019 | |
| Shire North American Group INC | $14.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Mcadams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.